FunPep

President and CEO

Toshimi
Miyoshi

Pharm. D, Ph.D

Experience in pharmaceutical companies (GlaxoSmithKline, Sanofi, etc.) and investment companies (MBL Venture Capital, Nikko Antfactory, Sosei CVC)
Became President & CEO in January 2020

Director of the Board and CSO

Hideki
Tomioka

MD, Ph.D

Joined Ono Pharmaceutical in 1997 and AnGes in 2005
Joined FunPep in July 2015 and became CSO and Director of the Board in December 2015

Director of the Board and CFO

Taketoshi
Hayashi

Joined Fuji Research Institute in 1997, AnGes in 2001, CanBas in 2010, and Delta-Fly Pharma in 2014
Joined FunPep in May 2015 and became CFO and Director of the Board in December 2015

Director of the Board

Norikazu
Eiki

Previously President and CEO of Bayer Yakuhin
Served as external director of the board at various pharmaceutical companies and bioteches (AnGes, Towa Pharmaceutical, Solasia Pharma, Kidswell Bio)
Became Director of the Board of FunPep from March 2015

Director of the Board

Tsutomu
Une

Ph.D

Previously Member of the Board and Senior Executive Officer of Daiichi Sankyo
Became Director of the Board of FunPep from March 2022

Director of the Board

Hiroshi
Kubota

Previously Representative Director of Senshu Ikeda Holdings
Became Director of the Board of FunPep from March 2022

Corporate Auditor

Motoji
Horiguchi

Previously Director and Executive Officer & Director of the Management Division at SymBio Pharmaceutical
Became Corporate Auditor of FunPep in March 2015

Corporate Auditor

Naruhito
Minami

CPA

Chairman of GYOSEI & Co., Executive Director of Japan Institute of Certified Public Accountants
Became Corporate Auditor of FunPep in March 2015

Corporate Auditor

Junya
Manabe

Attorney at Law
CPA

Minamiaoyama M's Law Accounting Firm
Became Corporate Auditor of FunPep in March 2022